(Q83459939)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

ChEBI release 2020-05-28

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Arne Ring

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

C Friedrich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

T Brand

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

R Sennewald

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

E U Graefe-Mody

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

H-J Woerle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

22 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Drug Metabolism and Pharmacokinetics

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

17-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21340661%20AND%20SRC:MED&resulttype=core&format=json

Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial.

23 January 2020

cites work

1 reference

12 December 2020

Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356)--investigations in DPP-4 deficient and wildtype rats

1 reference

12 December 2020

A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay

1 reference

12 December 2020

Organic anion-transporting polypeptide (OATP) transporter family and drug disposition

1 reference

12 December 2020

Evaluation of pharmacokinetic interactions between vildagliptin and digoxin in healthy volunteers

1 reference

12 December 2020

Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib

1 reference

12 December 2020

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients.

1 reference

12 December 2020

8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes

1 reference

12 December 2020

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers

1 reference

12 December 2020

Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes

1 reference

12 December 2020

Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus.

1 reference

12 December 2020

Effect of linagliptin (BI 1356) on the steady-state pharmacokinetics of simvastatin

1 reference

12 December 2020

The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, in humans

1 reference

12 December 2020

Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes.

1 reference

12 December 2020

Evaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DPP-4 inhibitor linagliptin and metformin in healthy subjects.

1 reference

12 December 2020

Association of serum digoxin concentration and outcomes in patients with heart failure

1 reference

12 December 2020

P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs

1 reference

12 December 2020

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

1 reference

12 December 2020

Absence of an effect of a single-dose deferasirox on the steady-state pharmacokinetics of digoxin

1 reference

12 December 2020